You can buy or sell Cerecor and other stocks, options, ETFs, and crypto commission-free!
Cerecor Inc. Common Stock, also called Cerecor, is a clinical stage biopharmaceutical company focuses in medical development. Read More It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.
52 Week High
52 Week Low
Seeking AlphaMar 5
Cerecor secures $8M capital raise
Cerecor (NASDAQ:CERC) inks an agreement with H.C. Wainwright for the minimum purchase of ~1.5M shares of common stock that it will sell to public investors at $5.50 per share.
Stock Price, News, & Analysis for Cerecor
Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation. It also offers Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension; and Flexichamber. The company is develop...
Simply Wall StFeb 22
The Cerecor Share Price Has Gained 67% And Shareholders Are Hoping For More
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! By buying an index fund, you can roughly match the market return with ease. But if you pick the right individual stocks, you could make more than that. Just take a look at Cerecor Inc. (NASDAQ:CERC), which is up 67%, over three years, soundly beating the market return of 54%. On the other hand, the returns haven’t been quite so good recently, with shareholders up just 28%. Check out our latest ...
-$0.18 per share